Treatment of gastroparesis with low-dose erythromycin and low-bulk diet results in a dramatic short-term improvement in the majority of patients. Short-term response predicts long-term response. This response may not be as great, possibly due to tachyphylaxis.

Although numerous drugs have been implicated in the etiology of acute pancreatitis, literature on various aspects of drug-induced pancreatitis is sparse and limited mostly to case reports. Accurate diagnosis and management of this rare entity can be a challenge. This review discusses the clinical and epidemiological features of drug-induced pancreatitis, commonly associated drugs and conditions, possible pathogenic mechanisms, and a systematic approach to the diagnosis and management of drug-induced pancreatitis.

No abstract

No abstract